CVE-2023-40279

Published: Mar 19, 2024Modified: Apr 14, 2025

7.5

Vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Exploitability: 3.9 / Impact: 3.6

Source: 134c704f-9b21-4f2e-91b3-4a467353bcc0 (Secondary)

Description

An issue was discovered in OpenClinic GA 5.247.01. An attacker can perform a directory path traversal via the Page parameter in a GET request to main.do.

Affected (1)

Products: Openclinic Ga Project: Openclinic Ga

Openclinic Ga Project

1 product

Openclinic Ga

Configuration A

1 vulnerable

Vulnerable Software	Affected Versions
Openclinic Ga Project Openclinic Ga	Version 5.247.01

Related CWEs

CWE-22

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.

References (4)

https://github.com/BugBountyHunterCVE/CVE-2023-40279/blob/main/CVE-2023-40279_Authenticated-Directory-Path-Traversal_OpenClinic-GA_5.247.01_Report.md

Source: cve@mitre.org

ExploitThird Party Advisory

https://sourceforge.net/projects/open-clinic/

Source: cve@mitre.org

Product

https://github.com/BugBountyHunterCVE/CVE-2023-40279/blob/main/CVE-2023-40279_Authenticated-Directory-Path-Traversal_OpenClinic-GA_5.247.01_Report.md

Source: af854a3a-2127-422b-91ae-364da2661108

ExploitThird Party Advisory

https://sourceforge.net/projects/open-clinic/

Source: af854a3a-2127-422b-91ae-364da2661108

Product

Timeline

No history available yet.